Cargando…
Letter to the editor regarding “The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients”
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178533/ https://www.ncbi.nlm.nih.gov/pubmed/34116850 http://dx.doi.org/10.1016/j.amjoto.2021.103103 |
_version_ | 1783703588599496704 |
---|---|
author | Verma, Ravneet Ravinder Gupta, Nitin Singh, Mugdha |
author_facet | Verma, Ravneet Ravinder Gupta, Nitin Singh, Mugdha |
author_sort | Verma, Ravneet Ravinder |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8178533 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81785332021-06-05 Letter to the editor regarding “The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients” Verma, Ravneet Ravinder Gupta, Nitin Singh, Mugdha Am J Otolaryngol Article Elsevier Inc. 2021 2021-06-05 /pmc/articles/PMC8178533/ /pubmed/34116850 http://dx.doi.org/10.1016/j.amjoto.2021.103103 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Verma, Ravneet Ravinder Gupta, Nitin Singh, Mugdha Letter to the editor regarding “The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients” |
title | Letter to the editor regarding “The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients” |
title_full | Letter to the editor regarding “The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients” |
title_fullStr | Letter to the editor regarding “The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients” |
title_full_unstemmed | Letter to the editor regarding “The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients” |
title_short | Letter to the editor regarding “The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients” |
title_sort | letter to the editor regarding “the outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in covid-19 patients” |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178533/ https://www.ncbi.nlm.nih.gov/pubmed/34116850 http://dx.doi.org/10.1016/j.amjoto.2021.103103 |
work_keys_str_mv | AT vermaravneetravinder lettertotheeditorregardingtheoutcomeoffluticasonenasalsprayonanosmiaandtriamcinoloneoralpasteindysgeusiaincovid19patients AT guptanitin lettertotheeditorregardingtheoutcomeoffluticasonenasalsprayonanosmiaandtriamcinoloneoralpasteindysgeusiaincovid19patients AT singhmugdha lettertotheeditorregardingtheoutcomeoffluticasonenasalsprayonanosmiaandtriamcinoloneoralpasteindysgeusiaincovid19patients |